| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| IXICO Aktie jetzt für 0€ handeln | |||||
| Di | IXICO plc - IXICO Updates AI Neuroimaging Platform | 1 | RNS | ||
| 27.04. | IXICO plc - Holding(s) in Company | 6 | RNS | ||
| 24.04. | IXICO plc - Holding(s) in Company | 3 | RNS | ||
| 22.04. | IXICO plc - Issue of Equity | 4 | RNS | ||
| 21.04. | IXICO plc - Trading Update | 4 | RNS | ||
| 16.04. | IXICO plc - Result of GM and Update on Issue of Equity | 4 | RNS | ||
| 31.03. | EARNINGS AND TRADING: Future takes "cautious view"; Ixico's fundraise | 8 | Alliance News | ||
| 31.03. | IXICO plc - Retail Offer | 7 | RNS | ||
| 31.03. | IXICO plc - Placings and Subscription | 7 | RNS | ||
| 26.03. | IXICO plc - Collaboration with Medidata | 7 | RNS | ||
| 26.02. | IXICO validates automated brain imaging analysis platform | 13 | Investing.com | ||
| 26.02. | IXICO: Automatisierte Analyseplattform für Gehirnbilder übertrifft manuelle Verfahren | 13 | Investing.com Deutsch | ||
| 26.02. | IXICO plc - Validation of Neuroimaging Technology Platform | 12 | RNS | ||
| 12.02. | IXICO secures £1.5 million contract extension for Huntington's trial | 25 | Investing.com | ||
| 12.02. | IXICO sichert sich Vertragsverlängerung über 1,5 Millionen Pfund für Huntington-Studie | 25 | Investing.com Deutsch | ||
| 12.02. | IXICO plc - Correction: c.£1.5 million Contract Extension | 24 | RNS | ||
| 12.02. | IXICO plc - c.£1.5 million Contract Extension | 24 | RNS | ||
| 05.02. | IXICO plc - Appointment of Chief Commercial Officer | 24 | RNS | ||
| 23.01. | IXICO shareholders approve all resolutions at annual meeting | 25 | Investing.com | ||
| 23.01. | IXICO plc - Results of AGM | 25 | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 40,635 | +2,47 % | Novo Nordisk hebt Prognose leicht an | ||
| AURORA CANNABIS | 2,826 | -1,40 % | AURORA CANNABIS INC: Ruhe vor dem nächsten Impuls | ||
| CANOPY GROWTH | 0,931 | -0,04 % | CANOPY GROWTH CORPORATION: Struktur im Stillstand | ||
| TILRAY BRANDS | 4,615 | 0,00 % | Tilray Brands Inc (2): Tilray Brands' Blue Point rolls out Magic Hour IPA | ||
| VERTEX PHARMACEUTICALS | 380,65 | -0,33 % | Vertex Pharmaceuticals Incorporated: Vertex Announces CASGEVY Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany | -The agreement ensures sustainable access to this innovative therapy for eligible patients ages 12 years and older in Germany- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today... ► Artikel lesen | |
| MPH HEALTH CARE | 21,700 | -0,46 % | Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen | Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH
05.05.2026 / 11:57 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer... ► Artikel lesen | |
| CRONOS GROUP | 2,330 | -1,10 % | Cronos Group Inc.: Cronos Group Reports 2026 First Quarter Results | Net revenue in Q1 2026 increased by 40% year-over-year to $45.2 million Achieved record net revenue and gross profit in Q1 2026 Reached #1 market share in vapes in Canada1 Ninth consecutive quarter... ► Artikel lesen | |
| SYNBIOTIC | 1,800 | +0,56 % | EQS-News: SYNBIOTIC SE: SYNBIOTIC startet mit operativem Fortschritt, neuen regulatorischen Impulsen und starker Branchenpräsenz ins Frühjahr 2026 | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Marktbericht/Prognose
SYNBIOTIC startet mit operativem Fortschritt, neuen regulatorischen Impulsen und starker Branchenpräsenz ins Frühjahr... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | +14,29 % | Digicann Ventures Inc.: Digicann Ventures Announces Resignation of Director | Vancouver, British Columbia--(Newsfile Corp. - April 8, 2026) - Digicann Ventures Ltd. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis... ► Artikel lesen | |
| EYEPOINT | 11,500 | -1,71 % | EyePoint, Inc.: EyePoint Reports First Quarter 2026 Financial Results and Highlights Recent Corporate Developments | Phase 3 wet AMD trials, LUGANO and LUCIA, remain on track with topline data expected beginning mid-2026 -Phase 3 DME clinical trials, COMO and CAPRI, rapidly advancing with over one-third of patients... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,975 | +2,63 % | Organigram Says Vape Weakness Pressures Margins | ||
| GREEN THUMB INDUSTRIES | 6,370 | -2,45 % | Green Thumb Industries Reports First Quarter 2026 Results | CHICAGO and VANCOUVER, British Columbia, May 06, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| SNDL | 1,184 | -1,09 % | SNDL Inc.: SNDL Reports First Quarter 2026 Financial and Operational Results | EDMONTON, Alberta, April 29, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) ("SNDL" or the "Company") reported its financial and operational results for the first quarter ended March... ► Artikel lesen | |
| SINOPHARM | 2,006 | -0,79 % | Reed Sinopharm Exhibitions (RSE): PCHi 2026: World's Largest Cosmetics Ingredients Exhibition Opens in Hangzhou | 860+ exhibitors from 26 countries and regions across 70,000 sqmClose to 50 new product launches, including global and China debuts295 product submissions and 19 engineer nominations for the... ► Artikel lesen | |
| NOVERIS HEALTH SCIENCES | 0,890 | 0,00 % | XFRA 0NF1: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |